Cross-Strait Clinical Tests Open Door for Taiwan Pharmaceutical Firms

Taiwan and Mainland China recently recognized for the first time the results of clinical drug tests conducted by four hospitals on both sides of the Taiwan Strait, paving the way for local pharmaceutical firms to further tap the growing mainland Chinese market.

This breakthrough eliminates the need to conduct another set of clinical trials in mainland China, cutting considerable time off the approval process for drug-makers developing new products. It helps drug-makers earn more money from sales of their products while protected by patents, and multinational pharmaceutical companies targeting the mainland Chinese market will now be more interested in conducting clinical trials in Taiwan.

See original article

Anemone Ventures Ltd
© 2020 Anemone Ventures Ltd. All Rights Reserved. Designed By as2
Font Size Normal Large Huge
Site color display * Works on modern browsers Normal Display For color blind For disabled
Site Design Normal site design Content only, no sesign